Westchester Capital Management (New York)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-263,700
Closed -$15.5M 162
2014
Q1
$15.5M Buy
263,700
+12,800
+5% +$714K 0.2% 100
2013
Q4
$12.8M Hold
250,900
0.19% 100
2013
Q3
$12.6M Sell
250,900
-650,500
-72% -$34.1M 0.23% 88
2013
Q2
$44.3M Buy
+901,400
New +$49M 0.82% 50

Other funds holding LLY

Westchester Capital Management (New York)'s LLY Position: Q2 2014 in Review

Westchester Capital Management (New York) sold out of Eli Lilly (LLY) in Q2 2014, closing a stake of 263,700 shares — an estimated $15.5M sold.

Westchester Capital Management (New York) first reported a position in LLY in Q2 2013 and held it in 4 quarters. The position peaked at $44.3M in Q2 2013. 1,029 funds tracked by Wall St. Rank hold LLY as of Q2 2014.

  • Westchester Capital Management (New York) reported no remaining Eli Lilly position as of Q2 2014 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 263,700 Eli Lilly shares in Q2 2014, an estimated $15.5M.
  • Westchester Capital Management (New York) first reported a position in Eli Lilly in Q2 2013 and held it in 4 quarters.
  • Westchester Capital Management (New York)'s Eli Lilly position peaked at $44.3M in Q2 2013.
  • 1,029 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2014.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2014, filed 14 Aug 2014.